The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review.
暂无分享,去创建一个
N. Bansback | A. Anis | L. Davies | D. Symmons | M. Harrison | M. Ingram
[1] S A Marion,et al. Not all "quality-adjusted life years" are equal. , 2007, Journal of clinical epidemiology.
[2] Dan Greenberg,et al. Trends in the measurement of health utilities in published cost-utility analyses. , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[3] J. Dekker,et al. Psychometric evaluation of osteoarthritis questionnaires: a systematic review of the literature. , 2006, Arthritis and rheumatism.
[4] Angela Robinson,et al. Exploring challenges to TTO utilities: valuing states worse than dead. , 2006, Health economics.
[5] D. Symmons,et al. The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis. , 2005, The Journal of rheumatology.
[6] Jacek A Kopec,et al. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. , 2005, Social science & medicine.
[7] Stephen Joel Coons,et al. US Valuation of the EQ-5D Health States: Development and Testing of the D1 Valuation Model , 2005, Medical care.
[8] T. Ganiats,et al. Comparison of Measured Utility Scores and Imputed Scores From the SF-36 in Patients With Rheumatoid Arthritis , 2005, Medical care.
[9] C. McHorney,et al. Individual-patient monitoring in clinical practice: are available health status surveys adequate? , 1995, Quality of Life Research.
[10] John E. Brazier,et al. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D , 2005, Quality of Life Research.
[11] M. Abrahamowicz,et al. Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? , 2005, Quality of Life Research.
[12] J. Kopec,et al. A Comparison of Four Indirect Methods of Assessing Utility Values in Rheumatoid Arthritis , 2004, Medical care.
[13] R. Kaplan,et al. Arthritis Impact on U.S. Life Quality: Morbidity and Mortality Effects From National Health Interview Survey Data 1986–1988 and 1994 Using QWBX1 Estimates of Well-Being , 2004 .
[14] J. Brazier,et al. The Estimation of a Preference-Based Measure of Health From the SF-12 , 2004, Medical care.
[15] Validity of self-administered quality of well-being scale in musculoskeletal disease. , 2004, Arthritis and rheumatism.
[16] P. Geborek,et al. TNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow up study of patients with RA treated with etanercept or infliximab in southern Sweden , 2003, Annals of the rheumatic diseases.
[17] C. Terwee,et al. On assessing responsiveness of health-related quality of life instruments: Guidelines for instrument evaluation , 2003, Quality of Life Research.
[18] D. Feeny,et al. The Health Utilities Index (HUI®): concepts, measurement properties and applications , 2003, Health and quality of life outcomes.
[19] J. Thumboo,et al. A comparison of the EuroQol-5D and the Health Utilities Index mark 3 in patients with rheumatic disease. , 2003, The Journal of rheumatology.
[20] Robert M Kaplan,et al. Use of the quality of well-being self-administered version (QWB-SA) in assessing health-related quality of life in depressed patients. , 2003, Journal of affective disorders.
[21] M. Suarez‐Almazor,et al. Variation in the Estimation of Quality‐adjusted Life‐years by Different Preference‐based Instruments , 2003, Medical care.
[22] W. Maksymowych,et al. The responsiveness of generic health status measures as assessed in patients with rheumatoid arthritis receiving infliximab. , 2003, The Journal of rheumatology.
[23] J. Brazier,et al. What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D , 2003, Health and quality of life outcomes.
[24] Jacek A Kopec,et al. A comparative review of four preference-weighted measures of health-related quality of life. , 2003, Journal of clinical epidemiology.
[25] D. Franić,et al. EFFECT OF INCLUDING (VERSUS EXCLUDING) FATES WORSE THAN DEATH ON UTILITY MEASUREMENT , 2003, International Journal of Technology Assessment in Health Care.
[26] R. Fitzpatrick,et al. Quality of life measurement: bibliographic study of patient assessed health outcome measures , 2002, BMJ : British Medical Journal.
[27] J. Brazier,et al. The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.
[28] A. Young,et al. Modelling the costs and effects of leflunomide in rheumatoid arthritis , 2002, The European Journal of Health Economics.
[29] P. Ditto,et al. The stability of older adults' judgments of fates better and worse than death. , 2001, Death studies.
[30] W. Taylor,et al. EuroQol EQ-5D may not adequately describe the health of people with disabilities. , 2001, Disability and rehabilitation.
[31] M. Suarez‐Almazor,et al. Rating of arthritis health states by patients, physicians, and the general public. Implications for cost-utility analyses. , 2001, The Journal of rheumatology.
[32] Rachelle Buchbinder,et al. Functional Status and Health-related Quality of Life Assessment in Patients with Rheumatoid Arthritis , 2001 .
[33] D. Feeny,et al. Health Utilities Index Mark 3: evidence of construct validity for stroke and arthritis in a population health survey. , 2000, Medical care.
[34] J. Brazier,et al. A Review of the Use of Health Status Measures in Economic Evaluation , 1999, Journal of health services research & policy.
[35] B. Jönsson,et al. Economic consequences of the progression of rheumatoid arthritis in Sweden. , 1999, Arthritis and rheumatism.
[36] P. Tugwell,et al. The OMERACT filter for Outcome Measures in Rheumatology. , 1998, The Journal of rheumatology.
[37] F. Wolfe,et al. Measurement of the quality of life in rheumatic disorders using the EuroQol. , 1997, British journal of rheumatology.
[38] P. Kind,et al. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). , 1997, British journal of rheumatology.
[39] M. Weisman,et al. Quality-adjusted life years lost to arthritis: effects of gender, race,and social class. , 1996, Arthritis care and research : the official journal of the Arthritis Health Professions Association.
[40] K N Lohr,et al. Evaluating quality-of-life and health status instruments: development of scientific review criteria. , 1996, Clinical therapeutics.
[41] E. Jessop,et al. A comparison of measures of disability and health status in people with physical disabilities undergoing vocational rehabilitation. , 1996, Journal of public health medicine.
[42] P. Dolan,et al. Valuing health states: a comparison of methods. , 1996, Journal of health economics.
[43] Paul Kind,et al. A social tariff for EuroQol: results from a UK general population survey , 1995 .
[44] R. Kaplan. Using quality of life information to set priorities in health policy , 1994 .
[45] H. Brown,et al. Validity of Euroqol--a generic health status instrument--in patients with rheumatoid arthritis. Economic and Health Outcomes Research Group. , 1994, British journal of rheumatology.
[46] K C Cain,et al. Measuring Preferences for Health States Worse than Death , 1994, Medical decision making : an international journal of the Society for Medical Decision Making.
[47] J. Mcewen,et al. Measuring Health—A Review of Quality of Life Measurement Scales , 1992 .
[48] H. Hansluwka. Measuring health. A review of quality of life measurement scales: by Ann Bowling , 1992 .
[49] Ware J.E.Jr.,et al. THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .
[50] C. Bombardier,et al. A comparison of health-related quality-of-life measures for rheumatoid arthritis research* , 1991 .
[51] R A Deyo,et al. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. , 1991, Controlled clinical trials.
[52] A. Kasuya. EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.
[53] G H Guyatt,et al. Responsiveness and validity in health status measurement: a clarification. , 1989, Journal of clinical epidemiology.
[54] S. Wilson. Methods for the economic evaluation of health care programmes , 1987 .
[55] J. Fleiss. The design and analysis of clinical experiments , 1987 .
[56] D J Balaban,et al. Weights for Scoring the Quality of Well-being Instrument Among Rheumatoid Arthritics: A Comparison to General Population Weights , 1986, Medical care.
[57] G. Torrance. Measurement of health state utilities for economic appraisal. , 1986, Journal of health economics.
[58] George W. Torrance,et al. Application of Multi-Attribute Utility Theory to Measure Social Preferences for Health States , 1982, Oper. Res..
[59] H. Holman,et al. Measurement of patient outcome in arthritis. , 1980, Arthritis and rheumatism.